Check the syringe marking twice
Additionally, its ability to improve insulin sensitivity and regulate adipose tissue inflammation makes it an attractive candidate for managing metabolic disorders beyond diabetes, such as non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome
Many users add 1 ml for a stronger concentration or 2 ml for a slightly larger, easier-to-see draw
doi:10.4093/dmj.2025.0242 60
[DOI] [PubMed] [Google Scholar] 38.Pellesi L, Garcia-Azorin D, Rubio-Beltrn E, Ha W S, Messina R, Ornello R et al
About 19 percent of companies with 200 or more workers, and 43 percent of firms with 5,000 or more workers, covered GLP-1 drugs for weight loss in their largest health plan in 2025, according to research from the Peterson Center on Healthcare and the Kaiser Family Foundation (KFF)